Challenges in the Diagnosis of Hepatocellular Carcinoma in a 32‐Year‐Old Male With Hepatitis B and Alcohol Use Authors: E Syabbalo, N Mwanza, D Kaoma, C Shumbwa, P Chibuta, J Mulopwe, S Mupeta, M Mubbunu, E Sinkala Published: 2026 ABSTRACT ABSTRACTHepatitis B induced hepatocellular carcinoma (HCC) is an important cause of morbidity and mortality in sub‐Saharan Africa and particularly in Zambia presenting at a younger age compared to other regions globally and with poorer prognosis. Early diagnosis remains a challenge in low resource settings where advanced imaging, supportive serological testing, and histopathology services are limited, resulting in most cases of HCC being diagnosed late, usually clinically with more advanced disease and with limited treatment options. A 32‐year‐old male with chronic hepatitis B infection, anemic, and a 12‐year history of excessive alcohol use was referred from a district hospital for evaluation of HCC based on a positive hepatitis B surface antigen, an elevated alpha fetoprotein, and an abdominal ultrasound showing multiple hepatic masses. The atypical enhancement pattern of the steatotic variant of HCC in this patient failed to meet standard non‐invasive diagnostic criteria, precluding oncology referral under local protocols and necessitating tissue confirmation. Ultrasound‐guided biopsy was however definitive in the diagnosis. Significant challenges exist in the evaluation and confirmation of HCC in Zambia, contributing to delay in commencing the available treatment options. Additionally, unhealthy consumption of alcohol in chronic hepatitis B necessitates vigilant surveillance to detect hepatocellular carcinoma.Keywords: alcohol related liver disease, cirrhosis, hepatitis B, hepatocellular carcinoma, steatosis Introduction Chronic liver disease (CLD) is a significant global health burden accounting for 4% of deaths worldwide [1], with leading causes including chronic viral hepatitis (Hepatitis B and C), alcohol‐related liver disease (ArLD), and metabolic dysfunction associated with steatotic liver disease (MASLD). These conditions can progress to liver cirrhosis, leading to various complications including decompensation and hepatocellular carcinoma (HCC) [2]. HCC is a primary malignancy of the liver, often arising in the context of cirrhosis, and has a poor prognosis if not detected early. It is the 6th most diagnosed malignancy and 3rd most deadly cancer worldwide [3]. Hepatitis B is a significant contributor to HCC, associated with 39% of global cases and 66% of cases in sub‐Saharan Africa [4]. Chronic HBV in the background of unhealthy alcohol intake may accelerate chronic liver disease and subsequently HCC [5, 6] Compared internationally, HBV‐associated HCC tends to be diagnosed at a younger age in sub‐Saharan African populations, with the highest numbers being seen in the 3rd decade [7] and has a poorer outcome with median survival of 2.5 months from diagnosis [7]. HCC is the most common primary liver cancer and is one of the few cancers that can be diagnosed with imaging alone [8, 9], reducing the need for liver biopsy, which is associated with an array of complications. However, in resource‐limited settings, scarcity of advanced imaging and radiological services confounds diagnosis of this malignancy and delays much needed oncological referral. Furthermore, histological diagnosis typically takes several weeks due to the lack of experienced pathologists, pathology services, and immunohistochemistry in public institutions [10]. These gaps in radiological and laboratory diagnostics contribute significantly to the underreporting of cases, masking the true burden of disease, as may be evidenced by the 5‐year prevalence of primary liver cancer for Zambia of 2.9 per 100,000 being far below the global 5‐year prevalence of 14.8 per 100,000 [11]. We set out to discuss a case of HCC associated with a diagnostic delay and had a possible multiplicative effect of HBV and unhealthy alcohol consumption. Case History/Examination AL, a 32‐year‐old male subsistence farmer, was referred from a regional tertiary hospital in Kabwe located in the Central Province of Zambia to the University Teaching Hospital (UTH), the largest referral hospital in Zambia located in the capital city of Lusaka for evaluation of hepatocellular carcinoma following a positive hepatitis B surface antigen, an elevated alpha fetoprotein of 70.5 IU/mL (reference range < 10 IU/mL) and an abdominal ultrasound showing multiple hepatic masses. He presented with an 8‐month history of dull right upper quadrant pain and mass. Associated symptoms included two episodes of vomiting 2 days prior to admission, 2 days of constipation, difficulties in breathing, and a 1‐week history of a productive cough, chest pain, and night sweats. There was a history of dark stools but no history of hematemesis, hematochezia, or bleeding from any other site. The review of other systems was unremarkable. He was HIV negative with a history of an exploratory laparotomy for abdominal trauma sustained in 2019 after falling on a broken glass bottle resulting in evisceration and protrusion of bowels. However, surgical notes for the operation were not readily available, especially regarding the presence of any hepatic lesions at the time, and the patient could not recall all details related to the admission and operation although the incident resulted in his alcohol cessation. He had also started a fixed‐dose combination of tenofovir disoproxil and lamivudine for hepatitis B a week prior to referral which is typically the only available medication for hepatitis B in rural facilities. His father confirmed a history of a short illness at the age of 8 years associated with jaundice which could have represented acquisition of the hepatitis B infection. However, no tests were done at the time and further serological evaluation during admission to assess for chronicity of the infection could not be done due to financial challenges. He had no other significant past medical or other surgical history, and his family history was unremarkable. He endorsed excessive alcohol use for approximately 12 years with daily drinking of more than 5 bottles of alcohol a day and an AUDIT‐C score of 10. He also had a 5‐pack year smoking history and was in a polygamous marriage with two wives. He did use traditional medicine and scarification but denied intravenous drug use. The physical exam revealed a young man with a lean body habitus weighing 55.0 kg and normal distribution of hair with digital clubbing and clinically detectable pallor. He had a tender, craggy hepatomegaly with no ascites. There was discernible splenomegaly but no guarding or rebound tenderness on palpation of the abdomen. There was also a large midline scar on the abdomen with scarification marks in the shape of a target in the right upper quadrant as shown in Figure 1. Abdominal examination showing midline and left lower quadrant drain scar as well as a target shaped traditional scarification in the right upper quadrant. He was treated empirically with ceftriaxone 2 g once daily via intravenous (IV) administration on account of the difficulties in breathing and productive cough which were initially attributed to a suspected pneumonia, esomeprazole 80 mg once daily IV as peptic ulcer disease had been suspected, tramadol 50 mg three times daily IV for pain management, and lactulose 10 mls three times daily to treat any opioid‐related constipation. He also received a blood transfusion of one unit of packed red cells. Differential Diagnosis, Investigations and Treatment Investigations performed during the initial assessment of the patient were a full blood count with differential count, liver function tests with international normalized ratio (INR) and enzymes, creatinine and HIV test, repeat HBsAg test, TB urine LAM and a repeat alpha fetoprotein. The results are summarized below in Table 1 with reference ranges in brackets. TABLE 1Lab results.ValueReference rangeFull Blood Count and Differential CountWhite Cell Count ×10^9/L13.034.00–10.00Red Cell Count ×10^12/L2.564.50–5.50Hemoglobin g/dL7.114.3–18.3HCT %2140.0–50.0MCV fl8279.1–98.9MCH pg.27.727.0–32.0MCHC 33.8 g/dL33.832.0–36.0Red Cell Distribution Width %15.912.0–16.0Platelets ×10^9/L597150–400Liver function tests and enzymesBilirubin (unconjugated) μmol/L90–7Lactate Dehydrogenase (LDH) 228 IU/L228135–247Bilirubin (Total) μmol/L13.55.0–21.0Bilirubin (direct) μmol/L4.330.00–3.40Alanine transaminase (ALT) U/L11.80.0–45.0Aspartate transaminase (AST) U/L35.60.0–35.0Total Protein g/L7160.0–78.0Albumin g/L29.135.0–52.0International normalized ratio (INR)1.020.8–1.2Child Pugh A (6)Electrolytes and creatinineSodium mmol/L133136–145Potassium mmol/L3.73.50–5.10Chloride mmol/L100.398.0–107.0Creatinine μmol/L59.259.0–104.0 Lab results. A repeat alpha‐fetoprotein (AFP) was performed and was elevated at 775 IU/mL (normal range typically < 10 IU/mL), raising suspicion for HCC. HIV testing with Determine RDT was negative. Imaging studies included abdominal ultrasound and a 4‐phase contrast enhanced CT scan of the thorax, abdomen, and pelvis. Following the review of the imaging results, a decision was made to proceed with liver biopsy as they were still inconclusive for HCC despite being highly suggestive. The ultrasound and CT scan findings are shown below. Abdominal Ultrasound Repeat abdominal ultrasound with an experienced sonographer revealed an enlarged liver measuring 19.84 cm with multiple solid lesions and altered echotexture. Enlarged portal vein with multiple focal lesions involving the main portal vein, a highly concerning finding for tumor thrombus. It also revealed normal hepatic veins but an enlarged spleen. No ascites or abdominal lymphadenopathy were identified on sonography. CT Report Imaging findings were suggestive of an aggressive hepatic neoplasm with abdominal nodal and pulmonary metastasis and are shown in Figures 2, 3, 4. A differential diagnosis of atypical fibrolamellar HCC, multifocal HCC, and cholangiocarcinoma hepatic metastasis was provided. It was also suggested that further evaluation with contrast enhanced abdominal MRI was indicated for better characterization and to rule out portal invasion. Images are shown below: Axial view of the abdominal CT showing multifocal hepatocellular carcinoma. (A) Non‐contrasted CT image showing multiple hypodense lesions throughout the liver. (B) Arterial phase CT image showing multiple hypodense lesions in the liver lacking the classic arterial phase hyperenhancement. (C) Porto‐venous phase showing multiple hypodense lesions without classic washout. (D) Delay phase CT image. Coronal view of CT showing multifocal hepatocellular carcinoma. (A) Non‐contrasted CT image showing multiple hypodense lesions throughout the liver. (B) Arterial phase CT image showing multiple hypodense lesions in the liver lacking the classic arterial phase hyperenhancement. (C) Porto‐venous phase showing multiple hypodense lesions without classic washout. (D) Delay phase CT image. Coronal view of CT showing pulmonary metastases of hepatocellular carcinoma with asterisks highlighting areas of prominent metastases. Given the strong suspicion of HCC from the elevated AFP and suggestive imaging findings, an ultrasound‐guided bedside liver biopsy was performed to obtain tissue samples for histopathologic examination. Histopathology revealed liver tissue that was infiltrated by a neoplasm with a trabecular pattern of growth delicately intermingled with mature adipocytes and extensive fibrosis. The neoplastic cells were mildly pleomorphic and had round to oval hyperchromatic nuclei with eosinophilic to clear cytoplasm. Some hepatocytes showed ballooning and nuclear pseudoinclusion. Lymphovascular and perineural invasion were not identified. These histologic features were consistent with the steatotic variant of hepatocellular carcinoma, which is one of the recently described well differentiated variants [12]. The histology is shown in Figure 5. Histopathology showing trabecular pattern with steatosis in hepatocellular carcinoma. (A–C) Steatotic variant of hepatocellular carcinoma. (A) Low power view (×40) showing loss of normal liver architecture with fibrosis, and a neoplasm with a trabecular growth pattern. (B) Medium power view (×100) showing lobular disarray, and mature adipocytes within the neoplasm. An unpaired portal tract can also be seen. (C) High power view (×400) of the same tumor showing more extensive microvesicular steatosis and macrovesicular steatosis in the upper right corner. The neoplastic cells are mildly pleomorphic and have hyperchromatic nuclei and clear to eosinophilic cytoplasm. Conclusion and Results Apart from post‐procedure pain, no other complaints were noted, and the patient was discharged after liver biopsy following a 33‐day admission. He was reviewed 20 days post discharge with histology results and referred for further management to the Cancer Disease Hospital at the UTH where he was prescribed sorafenib, although due to the high cost, he was not able to afford treatment. Discussion HCC is the 7th most common primary liver cancer in Zambia and 4th in men [11]. It often arises in the setting of chronic liver disease, particularly due to HBV and alcohol‐induced liver injury. In this case report, although HCC was suspected, establishing a definitive diagnosis was hindered by multiple challenges. Several diagnostic modalities were employed; however, they were supportive rather than confirmatory. This scenario is common in the low resource setting like ours. In this case study, it took approximately 8 months of ongoing suspicion followed by an additional 33 days of inpatient evaluation before a diagnosis of HCC was reached. This time lapse is excessive and may contribute to disease progression. The differential diagnosis included intrahepatic cholangiocarcinoma, which under local guidance would require a tissue diagnosis before treatment could be considered, thus warranting a liver biopsy which was performed. Histologically, the trabecular pattern of HCC has been the most prevalent found in Zambia documented by Naik et al. in 1976 accounting for 87% (145/166) of biopsies [13]. In our patient, the histology revealed a trabecular pattern as well but as a steatotic variant which may be associated with MASLD, alcoholic liver disease [14] and viral hepatitis [15]. Several risk factors identified in our patient may have contributed to the development of HCC. These included hepatitis B infection, unhealthy alcohol use, male gender, and possible exposure to aflatoxin as a subsistence farmer. The multiplicative effects of these factors could have accelerated the development of HCC. With advances in molecular testing, identification of the mechanistic pathways of neoplastic transformation in our patient may have been possible through correlation of the histological subtypes with the specific molecular markers identified [16]. This patient presented with advanced stage HCC with markedly elevated alpha‐fetoprotein (AFP) and imaging findings suggestive but not diagnostic for HCC. While AFP alone lacks specificity, values above 400 ng/mL [17] are highly suggestive of HCC. Combining it with an imaging modality such as ultrasound enhances diagnostic accuracy [18]. Current EASL guidance favors a no‐biopsy approach, in the setting of hepatitis B and liver cirrhosis with The Liver Imaging Reporting and Data System (LI‐RADS) magnetic resonance imaging MRI/CT/ contrast enhanced ultrasound CEUS being the preferred imaging techniques [8] whilst AASLD guidance restricts the use of CEUS [9]. Use of novel biomarkers for early detection of HCC such as des‐gamma carboxyprothrombin (DCP) also known as Protein Induced by Vitamin K Absence‐II (PIKVA‐II) offers a promising option especially when coupled with AFP and as part of composite scores such as the GALAD score; however, they still have their limitations and are not currently recommended by EASL or AASLD for HCC surveillance. Several factors contributing to the late presentation and delayed referral to appropriate care were identified. The patient may have presented earlier than the 8‐month period of symptoms, but delayed referral may have led to his late diagnosis. In a country with intermediate prevalence (5.6%) for HBV such as Zambia [19], early detection of HBV and continued monitoring for indications for treatment with prompt initiation in eligible patients is crucial. In addition, continued surveillance for HCC using ultrasound, which is readily available in most centers, can lead to timely intervention. Alcohol consumption in the setting of HBV by the patient may have been addressed by timely referral to addiction services that would have limited hepatic injury and chronic inflammation precipitating neoplastic transformation, but these services are few and far between in the country, scattered amongst the urban centers. Despite the presence of an alcohol policy in the country, more efforts are required to enforce it. Diagnostic capacity in rural health facilities is limited and access to specialized services such as pathology can only be accessed in the urban healthcare centers. By increasing diagnostic infrastructure, specialist care facilities as well as training more specialists for these facilities, access to care for patients with HCC can be improved. Conclusion Significant challenges exist in the evaluation and confirmation of HCC in Zambia, contributing to a delay in commencing the available treatment options. Patients with chronic HBV should have a robust surveillance system to possibly diagnose surgically curative HCC lesions early. Unhealth alcohol intake in patients with chronic HBV may accelerate chronic liver disease and possibly HCC. Author Contributions E. Syabbalo: conceptualization, investigation, visualization, writing – original draft, writing‐reviewing and editing. N. Mwanza: conceptualization, writing – original draft. D. Kaoma: conceptualization, writing – original draft. C. Shumbwa: visualization, writing – reviewing and editing. P. Chibuta: visualization, writing – reviewing and editing. J. Mulopwe: writing – reviewing and editing. S. Mupeta: writing – reviewing and editing. M. Mubbunu: writing – reviewing and editing. E. Sinkala: supervision, writing‐reviewing and editing. Funding The authors have nothing to report. Ethics Statement The authors have nothing to report. Consent Written informed consent was obtained from the patient for publication of this case report and accompanying images. Conflicts of Interest The authors declare no conflicts of interest. Acknowledgments The authors have nothing to report. Data Availability Statement All information related to this case is included in this published article. References Associated Data Data Availability Statement All information related to this case is included in this published article.